Montreal, Canada

Stanley Nattel

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: L'institut De Cardiologie De Montréal, Ottawa Heart Institute Research Corporation. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stanley Nattel. Retrieved from https://idiyas.com/inventor/stanley-nattel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stanley Nattel

Introduction

Stanley Nattel is a prominent inventor based in Montréal, Canada. He is known for his significant contributions to the field of cardiac research, particularly in the development of engineered stem cells. His work has the potential to revolutionize treatments for heart conditions.

Latest Patents

Nattel holds a patent for "Engineered stem cells and cellular products produced and secreted by such cells, methods of preparing, and uses thereof." This patent describes a cardiac explant-derived stem cell (EDC) that includes a gene encoding an intermediate-conductance Ca-activated K channel. The gene causes an overexpression of this channel, which is crucial for various cardiac functions. The patent also outlines methods for producing engineered EDCs with modulated bioelectric properties, as well as compositions for treating damaged myocardium using extracellular vesicles isolated from cultures of engineered EDCs.

Career Highlights

Throughout his career, Stanley Nattel has worked with esteemed organizations such as the Ottawa Heart Institute Research Corporation and the Institut De Cardiologie De Montréal. His research has focused on the intersection of stem cell technology and cardiac health, leading to innovative solutions for heart disease.

Collaborations

Nattel has collaborated with notable colleagues, including Patrick Vigneault and Darryl Davis. Their combined expertise has contributed to advancements in cardiac research and the development of new therapeutic approaches.

Conclusion

Stanley Nattel's work in engineered stem cells represents a significant advancement in cardiac treatment options. His innovative research continues to pave the way for future developments in the field of cardiology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…